Interestingly, chronic administration of the glucagon/GLP-1 agonist in diet-induced obese (DIO) mice was able to reverse obesity, to improve hepatic steatosis and glucose tolerance, to increase metabolic rate, to decrease body fat mass, to reduce feeding, and to increase energy expenditure [35]. The gene discussed is GLP1R; the disease is Obesity.